0001070081-18-000017.txt : 20180105 0001070081-18-000017.hdr.sgml : 20180105 20180105160806 ACCESSION NUMBER: 0001070081-18-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180103 FILED AS OF DATE: 20180105 DATE AS OF CHANGE: 20180105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Souza Marcio CENTRAL INDEX KEY: 0001707657 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 18513501 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 wf-form4_151518647228588.xml FORM 4 X0306 4 2018-01-03 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001707657 Souza Marcio C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 Chief Operating Officer Common Stock 2018-01-03 4 A 0 1079 0 A 1742 I By Spouse Stock Option (Right To Buy) 18.01 2018-01-03 4 A 0 75000 0 A 2028-01-02 Common Stock 75000.0 75000 D Stock Option (Right To Buy) 18.01 2018-01-03 4 A 0 2696 0 A 2028-01-02 Common Stock 2696.0 2696 I By Spouse Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2019. Upon vesting, each RSU will convert into one share of the issuer. Includes 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. /s/ Avraham S. Adler, attorney-in-fact 2018-01-05